Balak Das Kurmi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 29

Top Topics

Magnetic Nanoparticles

Signaling Pathway

Top Venues

Journal of drug targeting

Assay and drug development technologies

Stem cell reviews and reports

This page only lists publications with an associated author ORCID identifier.

Publications

Nitin Sharma, Balak Das Kurmi, Dilpreet Singh, Sidharth Mehan, Kushagra Khanna, Ritu Karwasra, Shobhit Kumar, Amit Chaudhary, Vikash Jakhmola, Anjana Sharma, Sachin Kumar Singh, Kamal Dua, Dipti Kakkar
Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategies. Journal of drug targeting (2024)
Nitin Sharma, Balak Das Kurmi, Dilpreet Singh, Sidharth Mehan, Kushagra Khanna, Ritu Karwasra, Shobhit Kumar, Amit Chaudhary, Vikash Jakhmola, Anjana Sharma, Sachin Kumar Singh, Kamal Dua, Dipti Kakkar
Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategies. Journal of drug targeting 32 (5) (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting 32 (5) (2024)
Abhinav Vashishat, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches. Stem cell reviews and reports 20 (4) (2024)
Sourabh Satapathy, Shivam Kumar, Balak Das Kurmi, Ghanshyam Das Gupta, Preeti Patel
Expanding the Role of Chiral Drugs and Chiral Nanomaterials as a Potential Therapeutic Tool. Chirality 36 (7) (2024)
Anjali Bisht, Dubey Avinash, Kantrol Kumar Sahu, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer. Drug delivery and translational research (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting (2024)
Nitin Sharma, Balak Das Kurmi, Dilpreet Singh, Sidharth Mehan, Kushagra Khanna, Ritu Karwasra, Shobhit Kumar, Amit Chaudhary, Vikash Jhakmola, Anjana Sharma, Sachin Kumar Singh, Kamal Dua, Dipti Kakkar
Nanoparticles toxicity: An overview of its mechanism and plausible mitigation strategies. Journal of drug targeting (2024)
Abhinav Vashishat, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches. Stem cell reviews and reports 20 (4) (2024)
Abhinav Vashishat, Md Moidul Islam, Ghanshyam Das Gupta, Balak Das Kurmi
Navigating Drug-Drug Interactions in Multimorbid Patients: Utilizing Tools, Guidelines, and Clinical Implications. Current drug safety (2024)
Abhinav Vashishat, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches. Stem cell reviews and reports (2024)
Nitin Sharma, Balak Das Kurmi, Dilpreet Singh, Sidharth Mehan, Kushagra Khanna, Ritu Karwasra, Shobhit Kumar, Amit Chaudhary, Vikash Jakhmola, Anjana Sharma, Sachin Kumar Singh, Kamal Dua, Dipti Kakkar
Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategies. Journal of drug targeting 32 (5) (2024)
Anjali Bisht, Shuvadip Bhowmik, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Aptamer as a targeted approach towards treatment of breast cancer. Journal of drug targeting 32 (5) (2024)
Pallavi Sandal, Preeti Patel, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line. Assay and drug development technologies (2023)
Lakshmi Kumari, Yash Choudhari, Preeti Patel, Ghanshyam Das Gupta, Dilpreet Singh, Jessica M Rosenholm, Kuldeep Kumar Bansal, Balak Das Kurmi
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs. Life (Basel, Switzerland) 13 (5) (2023)
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Dilpreet Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. Assay and drug development technologies (2023)
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Dilpreet Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. Assay and drug development technologies (2023)
Shivanshu Pandey, Sitanshu Mondal, Kumari Kajal, Balak Das Kurmi, Sant Kumar Verma, Preeti Patel
Current progress in the targeted therapy of breast cancer: Structure-activity correlation and docking studies (2015-2021). Archiv der Pharmazie (2023)
Balak Das Kurmi, Preeti Patel, Rishi Paliwal, Pramod Kumar, Shivani Rai Paliwal
Multifunctional nanotherapeutics for intracellular trafficking of doxorubicin against breast cancer. Nanomedicine (London, England) (2023)
Akshay Kumar, Balak Das Kurmi, Dilpreet Singh
Development and Method Validation of Design of Experiments-Optimized Tablet Formulation for Simultaneous Detection of Exemestane and Everolimus. Assay and drug development technologies (2023)
Abhinav Vashishat, Ghanshyam Das Gupta, Balak Das Kurmi
Revolutionizing Drug Discovery: The Role of AI and Machine Learning. Current pharmaceutical design (2023)
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Dilpreet Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. Assay and drug development technologies (2023)
Pallavi Sandal, Lakshmi Kumari, Preeti Patel, Dilpreet Singh, Dilpreet Singh, Ghanshyam Das Gupta, Balak Das Kurmi
Doxorubicin Conjugates: An Efficient Approach for Enhanced Therapeutic Efficacy with Reduced Side Effects. Assay and drug development technologies (2023)
Kanak Chahar, Yash Sharma, Preeti Patel, Vivek Asati, Balak Das Kurmi
A mini-review on recent strategies and applications of nanomedicines to combat Antimicrobial Resistance. Current drug metabolism (2023)
Lakshmi Kumari, Lopamudra Mishra, Yash Sharma, Kanak Chahar, Mritunjay Kumar, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
NOTCH Signaling Pathway: Occurrence, Mechanism, and NOTCH-Directed Therapy for the Management of Cancer. Cancer biotherapy & radiopharmaceuticals (2023)
Mritunjay Kumar, Yash Sharma, Kanak Chahar, Lakshmi Kumari, Lopamudra Mishra, Preeti Patel, Dilpreet Singh, Balak Das Kurmi
Validation of a Novel Supercritical Fluid Extractor/Dryer Combo Instrument. Assay and drug development technologies (2023)
Lopamudra Mishra, Shuvadip Bhowmik, Rajveer Singh, Preeti Patel, Ghanshyam Das Gupta, Balak Das Kurmi
Quality by design-assisted development of D-α-tocopherol polyethylene glycol 1000 succinate-incorporated gefitinib-loaded cationic liposome(s). Therapeutic delivery (2023)
Akshay Kumar, Balak Das Kurmi, Amrinder Singh, Dilpreet Singh
Potential role of resveratrol and its nano-formulation as anti-cancer agent. Exploration of targeted anti-tumor therapy 3 (5) (2022)